Dardinger Laboratory for Neuro oncology and Neurosciences

Laboratory for, United States

Dardinger Laboratory for Neuro oncology and Neurosciences

Laboratory for, United States
SEARCH FILTERS
Time filter
Source Type

Peruzzi P.,Dardinger Laboratory for Neuro oncology and Neurosciences | Bronisz A.,Brigham and Women's Hospital | Bronisz A.,Ohio State University | Nowicki M.O.,Brigham and Women's Hospital | And 16 more authors.
Neuro-Oncology | Year: 2013

BackgroundThe Polycomb Repressor Complex (PRC) is an epigenetic regulator of transcription whose action is mediated by 2 protein complexes, PRC1 and PRC2. PRC is oncogenic in glioblastoma, where it is involved in cancer stem cell maintenance and radioresistance.MethodsWe used a set of glioblastoma patient samples, glioma stem cells, and neural stem cells from a mouse model of glioblastoma. We characterized gene/protein expression and cellular phenotypes by quantitative PCR/Western blotting and clonogenic, cell-cycle, and DNA damage assays. We performed overexpression/knockdown studies by lentiviral infection and microRNA/small interfering RNA oligonucleotide transfection.ResultsWe show that microRNA-128 (miR-128) directly targets mRNA of SUZ12, a key component of PRC2, in addition to BMI1, a component of PRC1 that we previously showed as a target as well. This blocks the partially redundant functions of PRC1/PRC2, thereby significantly reducing PRC activity and its associated histone modifications. MiR-128 and SUZ12/BMI1 show opposite expression in human glioblastomas versus normal brain and in glioma stemlike versus neural stem cells. Furthermore, miR-128 renders glioma stemlike cells less radioresistant by preventing the radiation-induced expression of both PRC components. Finally, miR-128 expression is significantly reduced in neural stem cells from the brain of young, presymptomatic mice in our mouse model of glioblastoma. This suggests that loss of miR-128 expression in brain is an early event in gliomagenesis. Moreover, knockdown of miR-128 expression in nonmalignant mouse and human neural stem cells led to elevated expression of PRC components and increased clonogenicity.ConclusionsMiR-128 is an important suppressor of PRC activity, and its absence is an early event in gliomagenesis. © The Author(s) 2013. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved.

Loading Dardinger Laboratory for Neuro oncology and Neurosciences collaborators
Loading Dardinger Laboratory for Neuro oncology and Neurosciences collaborators